bpc157

BPC-157 is a synthetic peptide with promising, largely animal-based evidence for tissue repair, but its effects and safety in people remain uncertain. 1 2

• Healing mechanism: In animal studies, it promotes new blood-vessel formation (angiogenesis) and fibroblast migration and growth at injury sites—processes that may support tissue repair. 3 4
• Human evidence: Human research is sparse; the cited human evidence is described as a poorly conducted, self-report study rather than a rigorous clinical trial. Reported recovery benefits are largely anecdotal, so efficacy in people is not established. 2 5
• Tumor concern: Because BPC-157 may promote blood-vessel growth, increased vascularization could theoretically support tumor growth if a tumor is present; this is a caution based on mechanism, not demonstrated tumor growth in the available animal literature. 6 7
• Dosing mentioned: Typical doses described are 300–500 micrograms subcutaneously two or three times weekly, often for about eight weeks, followed by an 8–10-week break. The discussion cautions against continuous use; this is not an endorsement or individualized dosing advice. 8